Thermo Fisher Scientific Inc.
Thermo Fisher Scientific is a globally renowned leader in scientific solutions, now a top provider in the Central Lab Services market following the strategic acquisition of PPD, Inc. in December 2021. PPD is a premier clinical research organization that now operates within Thermo Fisher’s Laboratory Products and Biopharma Services segment. This integration enabled Thermo Fisher to offer comprehensive, end-to-end clinical research services, significantly expanding its presence in central lab and clinical trial lab services. The company provides new technologies and pharma services through a portfolio of powerful brands including Thermo Scientific, Applied Biosystems, and Patheon. By leveraging its vast global infrastructure, advanced technologies, and scientific expertise, Thermo Fisher delivers high-throughput, reliable, and scalable laboratory services necessary for supporting global clinical trials, accelerating drug discovery, and facilitating diagnostics development for pharmaceutical and biotech firms worldwide.
Latest Market Research Report on Central Lab Services Download PDF Brochure Now
IQVIA
IQVIA, a prominent global provider of advanced analytics, technology solutions, and clinical research services, stands as a top-tier player in the Central Lab Services market. The company was formed from the merger of Quintiles and IMS Health, and its operations in central lab services are primarily housed within its Research & Development Solutions segment. This segment offers a comprehensive suite of laboratory services, supporting clinical development from preclinical testing through post-launch monitoring for biopharmaceutical, pharmaceutical, and medical device companies. IQVIA Laboratories is a key component, delivering central laboratory, specialty biomarker, and clinical genomics laboratory services. The company emphasizes site and patient-centric solutions, exemplified by its Site Lab Navigator with e-Requisition innovation, designed to streamline clinical trial workflows, enhance data accuracy, and ensure timely, reliable outcomes for complex global studies.
Labcorp
Laboratory Corporation of America Holdings (Labcorp) is a global healthcare diagnostics company and a foundational leader in Central Lab Services, primarily through its drug development business, Covance. Labcorp provides comprehensive clinical laboratory services globally, offering an unmatched scope of services that integrates routine testing with highly specialized esoteric testing. Its central lab offering, Covance Central Laboratory Services, is repeatedly recognized for its global investigator satisfaction, which is critical for successful clinical trials. Labcorp/Covance supports the entire drug development life cycle for biopharmaceutical sponsors, with a robust portfolio spanning genetic services, biomarker services, anatomic pathology, and specimen management. Recent strategic expansions, including an integrated central laboratory in Singapore and new diagnostics facilities in the U.S., solidify Labcorp’s position as a key global partner in accelerating clinical research and providing innovative solutions.
Quest Diagnostics
Quest Diagnostics is a leading provider of diagnostic information services and a significant force in the Central Lab Services market, offering comprehensive clinical trials support. The company operates a vast network of laboratories, including state-of-the-art facilities with advanced automation capable of processing hundreds of thousands of tests daily. Quest provides a wide spectrum of diagnostic testing, including molecular diagnostics, genetic screenings, and infectious disease testing, which are essential for clinical trials. Their focus on high-volume, high-quality testing and rapid turnaround times helps streamline clinical workflows for pharmaceutical and biotech clients. Quest’s investment in precision medicine and its ability to deliver accurate, actionable, and timely data on a massive scale positions it as a vital partner for global clinical research and diagnostics development.
ICON plc
ICON plc is a globally recognized Contract Research Organization (CRO) and a leading player in the Central Lab Services market. Recognized as one of the top three leaders in the clinical trial lab services market, ICON is essential for pharmaceutical, biotechnology, and medical device industries. The company provides fully integrated clinical development solutions, with its central laboratory services forming a critical component of its end-to-end support for global trials. ICON Central Laboratories offers a comprehensive test menu and utilizes its global laboratory network to provide standardized, high-quality, and reliable data across all phases of clinical development. The company’s focus on leveraging technology, extensive therapeutic experience, and a strong market presence ensures that it maintains its dominant position in supporting complex, multinational clinical research programs.
Medpace
Medpace is a scientifically-driven, global Contract Research Organization (CRO) that stands out in the Central Lab Services market by operating four wholly-owned, fully-integrated central and bioanalytical laboratories across the globe. This unique, integrated model allows for efficient and streamlined execution of clinical trials from Phase I through Phase IV. Medpace’s Central Lab Services offer comprehensive support across six continents, featuring standardized testing platforms, a vast test menu, and a high degree of customization for clinical projects. Key services include microbiology, histology, molecular and genomics, and biomarker development. The company provides a seamless, integrated data management solution through its web-based ClinTrak Lab portal, ensuring the delivery of reliable and timely outcomes, thereby accelerating the development of safe and effective medical therapeutics.
Eurofins Scientific
Eurofins Scientific is an international group of laboratories providing a portfolio of over 200,000 analytical methods. Eurofins Central Laboratory is a major global contributor to the Central Lab Services market, specifically supporting the biopharmaceutical industry. The company operates a vast network of dedicated central laboratories across the world, offering a comprehensive and harmonized test menu for all phases of clinical trials. Eurofins’ services span across routine safety testing, specialized chemistry, microbiology, genomics, and advanced biomarker services. By committing to consistent quality, a global standardized approach, and extensive capacity, Eurofins supports complex, multinational clinical studies, helping clients efficiently manage their clinical trial logistics and ensuring the delivery of accurate and timely data.
Charles River Laboratories
Charles River Laboratories International, Inc. is a global provider of drug discovery and development services, with its central lab offerings being an integral part of its comprehensive portfolio. The company is a key player supporting the pharmaceutical, biotech, and medical device industries from discovery through preclinical and clinical development. Charles River’s Central Laboratory Services leverage its extensive scientific expertise and global footprint to provide high-quality, reproducible data for clinical trials. The company is actively involved in the development and validation of assays, biomarker services, and specimen management. By providing essential infrastructure and specialized testing, Charles River helps clients navigate the complexities of drug development, making it a critical partner in the life sciences sector and a significant force in the central lab services market.
Frontage Laboratories
Frontage Laboratories, Inc. is a global Contract Research Organization (CRO) that provides integrated, science-driven research services, including specialized Central Lab Services, to the biopharmaceutical industry. The company’s offerings span the entire drug discovery and development spectrum, from preclinical research to clinical trials support. Frontage’s Central Lab capabilities focus on delivering comprehensive and high-quality bioanalytical, biomarker, and specialty lab services. By leveraging its global facilities and deep scientific expertise, Frontage supports complex clinical studies, ensuring efficient sample processing, data analysis, and regulatory compliance. The company is committed to accelerating drug candidates’ progress to market by providing reliable and timely laboratory results for multinational clinical programs.
ACM Global Laboratories
ACM Global Laboratories is a recognized global leader in clinical trial testing services with over 40 years of experience. The company delivers state-of-the-art Central Lab Services to clinical trial programs in over 65 countries, providing actionable clinical insights on a global scale. ACM’s core offering includes Central Lab Services, Bioanalytical Services, and Toxicology Services, supported by wholly-owned and partner laboratories across the United States, Europe, and Asia. ACM specializes in customizing programs to address unique clinical trial specifications, ensuring strong sample management and data-driven decisions from inception to completion. Its robust global footprint, comprehensive test menu, and commitment to scientific expertise make it a key partner for biopharmaceutical clients navigating complex, multinational clinical studies.
Latest Market Research Report on Central Lab Services Download PDF Brochure Now